Consistent with this idea, CUL5 KO in CD8+ T cells resulted in an upregulation of TCR and cytokine/JAK/STAT signaling, which may subsequently increase the activity and expression of T cell-activation related transcription factors, biogenesis and metabolism enzymes, and cytotoxic effector molecules, leading to enhanced anti-tumor activity. Here, CUL5 is linked to neoplasm.